Synthesis, characterization of dinuclear vanadium(III) hydroquinonate–iminodiacetate complexes

Four electron selective O2 reduction by a tetranuclear vanadium(IV/V)/hydroquinonate catalyst: application in the operation of Zn–air batteries

A tetranuclear vanadium(IV/V) hydroquinonate electrocatalyst for oxygen reduction through proton-coupled electron transfer. The complex enhances the current and power of Zn–air batteries.

Screening possible drug molecules for Covid-19. The example of vanadium (III/IV/V) complex molecules with computational chemistry and molecular docking

We are still facing a Covid-19 pandemic these days and after the aggressively infection control measures taken by the governments in the whole world, there is a need of a rapid pharmaceutical solution in order to control this crisis. The computer aided chemistry and molecular docking is a rapid tool for drug screening and investigation. Moreover, more metal-based drugs are tested daily by research institutes for their antiviral activity. Here, we make use of theoretical studies on previously published biological active complex molecules of vanadium as an example of evaluating possible drug candidates before entering the laboratory. We used DFT calculation studies for structural elucidation and optimization of the molecules and molecular docking studies on several Covid-19 related proteins. Our findings suggest that drug discovery should always be computer -aided. Additionally, it is found that Vtocdea and VXn molecules are seem to be good candidates for further studies as antiviral agents.

Aerial Oxidation of a V(IV)-Iminopyridine Hydroquinonate Complex: A Trap for the V(IV)-Semiquinonate Radical Intermediate

The reaction of 2,5-bis[N,N'-bis(2-pyridyl-aminomethyl)aminomethyl]-p-hydroquinone (H2bpymah) with VO(2+) salts in acetonitrile or water at a low pH (2.2-3.5) results in the isolation of [{V(IV)(O)(Cl)}2(μ-bpymah)], the p-semiquinonate complex [{V(IV)(O)(Cl)}2(μ-bpymas)](OH), the cyclic mixed-valent hexanuclear compound [{V(V)(O)(μ-O)V(IV)(O)}(μ-bpymah)]3, and [(V(V)O2)2(μ-bpymah)]. [{V(IV)(O)(Cl)}2(μ-bpymas)](OH) is an intermediate of the radical-mediated oxidation of [{V(IV)(O)(Cl)}2(μ-bpymah)] from O2. At lower pH values (2.2), a reversible intramolecular electron transfer from the metal to the ligand of [{V(IV)(O)(Cl)}2(μ-bpymas)](OH) is induced with the concurrent substitution of chlorine atoms by the oxygen-bridging atoms, resulting in the formation of [{V(V)(O)(μ-O)V(IV)(O)}(μ-bpymah)]3. The metal complexes were fully characterized by X-ray crystallography, infrared (IR) spectroscopy, and magnetic measurements in the solid state, as well as by conductivity measurements, UV-vis spectroscopy, and electrochemical measurements in solution. The oxidation states of the metal ions and ligands were determined by the crystallographic data. The [{V(IV)(O)(Cl)}2(μ-bpymah)]-[{V(IV)(O)(Cl)}2(μ-bpymas)](OH) redox process is electrochemically reversible. The V(IV) ion in the semiquinonate compound exhibits a surprisingly low oxophilicity, resulting in the stabilization of OH(-) counterions at acidic pH values. An investigation of the mechanism of this reaction reveals that these complexes induce the reduction of O2 to H2O2, mimicking the activity of enzymes incorporating two redox-active centers (metal-organic) in the active site.